L’Oréal said the partnership “aims to explore the connection between beauty indicators and changes in epigenomic markers” and that it would “facilitate a series of innovative studies designed to unlock the intricate relationship between epigenetics and beauty,”
The world’s biggest beauty company said it planned to develop advanced products that promote long-term skin and hair health that “trigger the hallmarks of longevity activation moving to long term skin and hair health management.”
The firm also said that by focusing on the science of epigenetics, the two companies intended to develop ”groundbreaking solutions that enhance beauty-from-within, providing consumers with holistic approaches to skin care and hair care.”
New product offerings and valuable diagnostic insight
Head of open innovation and augmented beauty at L’Oréal, Guive Balooch, shared more on the move. “By combining our deep understanding of beauty biology with Tru Diagnostic’s cutting-edge expertise in epigenomics, we are poised to lead the field of Longevity biomarker discoveries that will bring new product offerings and valuable diagnostic insight to our consumers, to proactively care for their skin and hair health with the best longevity science solutions,” said Balooch.
Meanwhile the CEO of Tru Diagnostic, Matthew Dawson, said that epigenomics has “the potential to revolutionise how we understand beauty at a biological level. Together, we aim to lead the charge in integrating epigenetic science into the beauty industry, creating innovative products that truly reflect the future of beauty and longevity.”
L’Oréal’s Longevity Integrative Science focus
The move appears to be part of the L’Oréal Group’s wider focus on anti-ageing/longevity science, technology and the prejuvenation concept that’s making waves in beauty industry.
At the recent IMCAS 2025 conference in Paris, L’Oréal revealed more about what has been happening behind-the-scenes in its Longevity Integrative Science division.
This new approach to anti-ageing science explores how mechanisms in the human body can affect skin’s age and appearance and uncover the skin’s biological age rather than chronological age.
The company explained that there are a multitude of benefits including the ability to determine how fast skin is really aging, to advise on the right products to slow down the aging process and to inform beauty shoppers which active ingredients will be efficacious for their skin.
L’Oréal’s Longevity Integrative Science is based around nine hallmarks of ageing described as “nine interconnected biological mechanisms activated by the science of biomarkers.”
The scientific research is built around its technology innovation, the Longevity AI Cloud, which provides “a map of 267 biomarkers that enables us to create three intervention models and extend ‘skin healthspan’ in ways we never could before,” the firm said.
In terms of extending ‘skin healthspan’, L’Oréal said it has three intervention models corresponding to different life stages.
The first intervention is designed to “preserve skin’s youth capital at a molecular level.” The second ‘mid-age intercept’ can “halt metabolic dysfunctions at a cellular level,” while the third is a ‘mature age reset’ designed “to reverse damaged biological functions at a tissular level.”
Research director for microbiome and exposome at L’Oréal R&D Luc Aguilar, said this is still a relatively new area of research and highlighted that there are “a host of biomarkers and interventions” in this space.
He added that there is now generally “a global understanding and willingness to know your biological status at every stage of your life, to know and project the trajectories and change the trajectories before visible signs occur.”
